title: Natalizumab discontinuation in the increasing complexity of multiple sclerosis therapy.
authors.affiliation: From the Department of Health Sciences (M.P.S.), University of Genova; and the Department of Medicine Surgery and Neuroscience (N.D.S.), University of Siena, Italy.
authors.forename: Maria Pia
authors.initials: MP
authors.lastname: Sormani
authors.forename: Nicola
authors.initials: N
authors.lastname: De Stefano
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D000069442:Natalizumab